BP | All patients (n = 205) | Patients with target BP <140/90 mmHg (n = 156) | Patients with target BP <130/80 mmHg (n = 49) | Patients initiating HT appointments within the study period (n = 28) - First appointment | Patients initiating HT appointments within the study period (n = 28) - Last appointment |
---|---|---|---|---|---|
Mean ± SD SBP/DBP (mmHg) | 140.1 ± 15.0/81.5 ± 11.1 | 138.6 ± 14.4/81.9 ± 10.5 | 144.6 ± 16.2/80.4 ± 12.9 | 149.4 ± 17.1/87.3 ± 13.2 | 138.1 ± 11.0/83.7 ± 9.3 |
BP <140/90 (mmHg) | 91 (44%) | 71 (45.5%) | 20 (41%) | 6 (21%) | 11 (39%) |
BP ≥140/90 (mmHg) | 114 (56%) | 85 (54.5%) | 29 (59%) | 22 (79%) | 17 (61%) |
BP controlled (JCN 7 guidelines) | 76 (37%) | 71 (45.5%) | 5 (10%) | 6 (21.4%) | 10 (35.7%) |
BP not controlled | |||||
120-139/80-89 | 15 (7%) | NA | 15 (31%) | 0 | 1 (3.6%) |
Stage 1 | 92 (45%) | 71 (45.5%) | 21 (43%) | 13 (46.4%) | 16 (57.1%) |
Stage 2 | 22 (11%) | 14 (9%) | 8 (16%) | 9 (32.1%) | 1 (3.6%) |